U.S. Stock News

Booz Allen Hamilton (NYSE:BAH) has appointed former U.S. Army Chief Information Officer Leonel Garciga as Senior Executive Advisor. Garciga is expected to focus on artificial intelligence and defense technology initiatives across the firm’s government-focused business. The appointment centers on AI integration and large-scale technology transformation for defense clients. Booz Allen Hamilton, through its consulting and technology services, is deeply tied to U.S. federal defense and...

Earnings and buyback: what changed for XPO (XPO) XPO (XPO) has drawn fresh attention after reporting first quarter 2026 results alongside an update on its ongoing share repurchase program, giving investors new information on both profitability and capital allocation. For the quarter ended March 31, 2026, XPO reported sales of US$2,096 million compared with US$1,954 million a year earlier. Net income was US$101 million, compared with US$69 million in the prior year period. Basic earnings per...

Pitney Bowes (NYSE:PBI) received Impact Level 4 (IL4) Provisional Authorization for its SendPro 360 cloud platform. The IL4 approval permits use of SendPro 360 by the U.S. Department of Defense and authorized contractors. This accreditation expands access to secure federal technology workloads and supports the company’s government-focused offerings. Pitney Bowes, known for mailing, shipping, and related software, now has SendPro 360 cleared for higher security federal use through the IL4...

Why Disc Medicine’s latest trial milestones matter for investors Disc Medicine (IRON) has moved its pipeline forward by completing enrollment in the pivotal Phase 3 APOLLO trial of bitopertin in erythropoietic protoporphyria, while also preparing new data readouts across other hematology programs. See our latest analysis for Disc Medicine. The latest trial milestones arrive after a mixed stretch in the market, with the share price at US$67.53 showing a 1-year total shareholder return of...

What the latest earnings and guidance tell you about Commvault Systems (CVLT) Commvault Systems (CVLT) has drawn fresh attention after reporting fourth quarter and full year results that paired higher revenue with lower net income, alongside new fiscal 2027 guidance and an update on share repurchases. See our latest analysis for Commvault Systems. Commvault Systems' share price has moved sharply in recent weeks, with a 30.53% 1 month share price return and 20.11% 3 month share price return...

Guardant Health (GH) has just posted its FY 2025 numbers with Q4 revenue of US$281.3 million, a basic EPS loss of US$1.00 and net income loss of US$128.5 million, set against a trailing twelve month revenue base of US$982.0 million and a TTM EPS loss of US$3.32. Over recent quarters the company has seen revenue move from US$201.8 million in Q4 FY 2024 to US$281.3 million in Q4 FY 2025. Quarterly basic EPS losses have ranged between US$0.74 and US$1.00, and TTM net income losses have remained...

Why Greenbrier Companies (GBX) is on investors’ radar today Greenbrier Companies (GBX) has drawn attention after recent trading left the stock with a roughly 6% gain over the past month and a negative return over the past 3 months. See our latest analysis for Greenbrier Companies. The recent 2.6% 7 day share price return and 5.8% 30 day share price return at about $50 for Greenbrier Companies follows a weaker 90 day share price return. This sits alongside a 1 year total shareholder return...

Encore Capital Group (NasdaqGS:ECPG) is asking shareholders to approve an amendment to its corporate charter. The change would exculpate company officers from personal liability for monetary damages tied to breaches of the duty of care. The proposal is scheduled for a vote at the upcoming annual shareholder meeting. Encore Capital Group operates in the consumer debt buying and collections space, where regulatory scrutiny, legal risk and reputational considerations tend to be front and...

Hartford Insurance Group (NYSE:HIG) released its latest "Future of Benefits Study," examining how U.S. workers are choosing benefits as inflation pressures household budgets. The research highlights growing use of AI tools by employees, especially younger generations, to compare and select benefits options. The findings shed light on changing expectations of workplace benefits and potential shifts in how employers structure their offerings. For a company like Hartford, which has a broad...

Berkshire Hathaway’s 2026 annual meeting on May 2 and its first-quarter 2026 results highlighted Greg Abel’s first months as CEO, with revenue of US$93.68 billion and net income of US$10.11 billion, while shareholders rejected a proposal for expanded human-capital oversight reporting. Abel’s early tenure combined strong insurance and railroad performance, renewed share buybacks, and insider stock purchases, underscoring how Berkshire’s capital allocation and governance priorities are...

If you are wondering whether Alkermes at around US$35.40 still offers value, it helps to step back and look at what the recent share performance might be implying about expectations. The stock has returned 5.0% over the last 7 days, 7.2% over 30 days, 25.3% year to date and 16.5% over the past year. This puts recent pricing in clear focus for anyone weighing upside against risk. Recent coverage has centered on Alkermes’ position in the pharmaceuticals and biotech space and how its pipeline...

Wondering whether Privia Health Group at around US$23.99 is offering fair value or a potential opportunity? This article breaks down what the current price may be telling you. The stock has been volatile recently, with a 3.5% decline over the last 7 days, a 7.2% gain over the last 30 days, and year to date returns of 2.3% after a 4.3% loss over the past year. Those mixed returns come against a backdrop of ongoing interest in healthcare services companies focused on physician enablement and...

Motorola Solutions (MSI) closed out FY 2025 with fourth quarter revenue of US$3.4 billion and basic EPS of US$3.90, supported by net income of US$649 million. Trailing 12 month figures show revenue of US$11.7 billion and basic EPS of US$12.93. Over the past year, revenue has moved from US$10.8 billion to US$11.7 billion and basic EPS has gone from US$9.45 to US$12.93, alongside trailing 12 month net income rising from US$1.6 billion to US$2.2 billion. This sets the backdrop for a profit story...

If you are wondering whether IonQ's current share price lines up with its fundamentals, this article walks through the key signals investors often rely on when thinking about value. The stock last closed at US$47.68, with returns of 5.7% over 7 days, 67.4% over 30 days, 1.9% year to date and 49.7% over 1 year. This naturally raises questions about how much optimism is already reflected in the price. Recent coverage has focused on IonQ as a pure play in quantum computing, with attention on...

PG&E stock after recent performance shifts PG&E (PCG) has seen recent share price pressure, with the stock showing a 0.1% decline over the past day and a larger pullback over the past week, month, and past three months. See our latest analysis for PG&E. That short term weakness adds to a 1 month share price return of an 8.1% decline and a year to date share price return of a 0.5% decline, while the 5 year total shareholder return of 54.5% shows earlier momentum that has cooled in recent...

Ryman Hospitality Properties (RHP) has drawn fresh attention after reporting first quarter 2026 results, with sales of US$223.76 million and revenue of US$664.57 million, alongside net income of US$70.48 million. See our latest analysis for Ryman Hospitality Properties. The first quarter earnings and the recently declared US$1.20 second quarter dividend have come alongside a 30 day share price return of 17.63% and a 1 year total shareholder return of 19.82%. This suggests that momentum has...

Wondering whether Verra Mobility stock is starting to look appealing at its current price, especially after a tough run? This article focuses squarely on what that price might really imply about value. The stock last closed at US$14.63 and has returned 0.5% over 30 days, yet year to date it is down 34.5% and the 1 year return is a 39.7% decline, which can change how investors think about both risk and opportunity. Recent coverage has focused on how the stock's weaker 1 year and 3 year...

Serve Robotics (SERV) has posted FY 2025 results that highlight a small but growing top line alongside sizable losses, with Q4 revenue at about US$0.9 million and a quarterly net loss of roughly US$34.3 million, or EPS of US$0.46 loss, while trailing 12 month revenue sits at roughly US$2.7 million against a net loss of about US$101.4 million and EPS of US$1.63 loss. Over recent quarters the company has seen revenue move from around US$0.18 million in Q4 FY 2024 to US$0.88 million in Q4 FY...

Molson Coors Beverage (TAP) stock is reacting to fresh quarterly results, with first quarter sales of US$2,717.9 million and net income of US$151.3 million, along with a regular US$0.48 per share dividend declaration. See our latest analysis for Molson Coors Beverage. The first quarter update has come against a weak backdrop for the stock, with a 90 day share price return of a 16.67% decline and a 1 year total shareholder return of a 17.34% loss, so recent momentum has been fading despite...

Akebia Therapeutics, Inc. has reported past first-quarter 2026 results showing revenue of US$53.54 million versus US$57.34 million a year earlier, with net loss of US$9.05 million replacing prior net income of US$6.11 million. A recent proposal to increase authorized capital stock to 525,000,000 shares, including 500,000,000 common shares, adds a potential dilution and financing angle to Akebia’s weaker quarterly performance. Next, we’ll examine how the shift to a quarterly loss alongside...

Credit card refresh and Fort Lauderdale build out take center stage JetBlue Airways (JBLU) has put its co branded JetBlue Premier World Elite Mastercard and Fort Lauderdale expansion at the heart of its current push to win and retain travelers after Spirit Airlines’ shutdown. The card now offers larger statement credits, status related tile bonuses and a sizable limited time TrueBlue points offer. Fort Lauderdale is set to see new routes, added frequencies and targeted perks for former Spirit...

If you are wondering whether GitLab at around US$25.92 is priced attractively or not, the key is understanding what the current valuation is actually baking in for the future. The stock has recently been volatile, with a 17.1% return over the last 7 days and 12.0% over the last 30 days, yet it still sits on a year to date return of 28.4% decline and a 1 year return of 47.7% decline. Recent coverage has focused on GitLab as a software platform positioned in a competitive developer tools...

In early May 2026, Nano Nuclear Energy Inc. announced a non-binding Memorandum of Understanding with Super Micro Computer, Inc. to explore integrating its KRONOS MMR microreactors with Supermicro’s AI server and data center platforms to create on-site nuclear-powered AI infrastructure. This collaboration highlights how pairing microreactors with AI data centers could create self-powered, grid-independent computing hubs aimed at meeting rapidly rising electricity needs from artificial...

Bio-Rad Laboratories (BIO) stock is in focus after Q1 2026 results showed sales of US$592.1 million and a net loss of US$527.1 million, alongside weaker bioprocessing demand and cautious biotech spending. See our latest analysis for Bio-Rad Laboratories. The Q1 2026 net loss and reduced revenue outlook have been followed by a 7 day share price return of 8.14% decline and a year to date share price return of 15.71% decline, while the 1 year total shareholder return of 6.76% suggests longer...